Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Bin HuTian TianXin-Tao LiPei-Pei HaoWei-Chao LiuYing-Gui ChenTian-Yu JiangPei-Shan ChenYi ChengFu-Shan XuePublished in: Redox report : communications in free radical research (2023)
Dex postconditioning can alleviate myocardial IRI by suppressing oxidative stress and apoptosis, and these beneficial effects are at least partly mediated by activating the Nrf2/Sirt3/SOD2 signaling pathway.